Advertisement

FortuneIndia

Quick Links :

Fortune 500 India
40 Under 40
Most Powerful Women
Budget 2024
India's Richest
The Next 500
Best B-Schools
Opinion
First Edit
Multimedia
Events

Fortune 500 India
40 Under 40
Most Powerful Women
The Next 500
Best B-Schools
All Rankings
Events
Macro
Enterprise
Technology
Reviews
Venture
Investing
Multimedia
Fortune India Exchange
Bystander
Opinion
Infographics
Ideas
Long Reads
People
Buy on Amazon
Polemicist
Annual Subscription

budesonide inhalation suspension

Share

November 2023

Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Aurobindo Pharma has received approval from USFDA to produce and trade Budesonide Inhalation Suspension

By Fortune India

Advertisement

Top Stories

Nissan India to explore hybrid, CNG cars besides EV

Nissan India to explore hybrid, CNG cars besides EV

India on path of sustained high growth: PM Modi

India on path of sustained high growth: PM Modi

Typhoon Krathon to hit semicon supply chain from Taiwan

Typhoon Krathon to hit semicon supply chain from Taiwan

Sensex sinks 4,000 pts in 5 sessions amid ME tensions; investors' wealth eroded by ₹17 lakh cr

Sensex sinks 4,000 pts in 5 sessions amid ME tensions; investors' wealth eroded by ₹17 lakh cr

Apple to open 4 more stores in India by 2025

Apple to open 4 more stores in India by 2025

Advertisement

Advertisement

Top Stories

Nissan India to explore hybrid, CNG cars besides EV

Nissan India to explore hybrid, CNG cars besides EV

India on path of sustained high growth: PM Modi

India on path of sustained high growth: PM Modi

Typhoon Krathon to hit semicon supply chain from Taiwan

Typhoon Krathon to hit semicon supply chain from Taiwan

Sensex sinks 4,000 pts in 5 sessions amid ME tensions; investors' wealth eroded by ₹17 lakh cr

Sensex sinks 4,000 pts in 5 sessions amid ME tensions; investors' wealth eroded by ₹17 lakh cr

Apple to open 4 more stores in India by 2025

Apple to open 4 more stores in India by 2025

Contact Us
Vision & Core Values
Terms of Use
Privacy & Cookie Policy

Powered by Quintype